Saag Kenneth 2016Jane Knight Lowe Professor of Medicine

Vice Chair, Department of Medicine

Director, Center for Outcomes and Effectiveness Research and Education (COERE)
Director, Center for Education and Research on Therapeutics (CERTs)
Director, Center of Research Translation (CORT) in Gout and Hyperuricemia


Address: 
 

Faculty Office Tower (FOT), Room 820D
510 20th Street South
35294-3408

Telephone: (205) 996-9784
Email: ksaag@uabmc.edu

 

Education

BSE, Bioengineering, University of Michigan, Ann Arbor, 1982
MD, Northwestern University, Chicago, Illinois, 1986
MSc (Epidemiology), University of Iowa, Iowa City, IA,, 1993
Residency, Internal Medicine, Northwestern University, Evanston Hospital, Evanston, IL, 1986-1989
Chief Resident, Internal Medicine, Northwestern University, Evanston Hospital, Evanston, IL, 1989-1990
Fellowship, Rheumatology, University of Iowa, 1990-1993

 

Research Interests

Dr. Saag's current research focuses on the epidemiology of osteoporosis and rheumatoid arthritis as well as methods to translate evidence into practice for both arthritis and osteoporosis.

 

Publications

Click here for a more complete list of publications. below are a few selected papers.


Saag KG, Fitz-Patrick D, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, Becker MA. 2016. Lesinurad in Combination With Allopurinol: Randomized, Double-Blind, Placebo-Controlled Study in Gout Subjects With Inadequate Response to Standard of Care Allopurinol (A US-based Study). Arthritis Rheumatol.  [Epub ahead of print]. PMID: 27564409.


Cram P, Wolinsky FD, Lou Y, Edmonds SW, Hall SF, Roblin DW, Wright NC, Jones MP, Saag KG. 2016. Patient –activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporos Int. 10:3681-9 PMID: 27363400


Safford MM, Barasch A, Curtis JR, Outman R, Saag K. 2014. Bisphosphonates and Hip and Nontraumatic Subtrochanteric Femoral Fractures in the Veterans Health Administration. J Clin Rheum 20(7): 357-62. PMID: 25275761


Warriner AH, Outman RC, Feldstein AC, Roblin DW, Allison JJ, Curtis JR, Redden DT, Rix MM, Robinson BE, Rosales AG, Safford MM, Saag KG. 2014. Effect of Self-Referral on Bone Mineral Density Testing and Osteoporosis Treatment: A Randomized Trial. Medical Care.  52(8):743-50. PMID: 24984211. PMCID: PMC4101066.


Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R. 2007. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 357(20):2028-39. PMID: 18003959.


Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG. 1998. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. 339(5):292-9. PMID: 9682041

 

 

SOM Epilogue Menu